Cancer scientists have been working against the clock for decades to outsmart a disease that comes back more powerfully after ...

For immune cells, the actin cytoskeleton is more than a structural scaffold. Immune cells can migrate to sites of infection ...

Overall, she concludes by stating that adherence to these basic food safety measures — cleaning, separating, cooking, and ...

On 17 September 2025, Alexion Pharmaceuticals Inc. announced a study is to evaluate the efficacy of ALXN2030 compared with ...

Autumn is just around the corner, and many popular fruits harvested during this time of year support your immune system and heart. Learn more about their health benefits.

A new trial assessing the ability of COYA 302 to slow the progression of ALS will enroll up to 120 patients at sites in the U ...

More than 1500 persons in Norway have had a liver transplantation. But how can doctors know which patients need extra ...

Over 1500 people in Norway have had a liver transplantation. But how can doctors know which patients need extra follow-up or ...

Emerging therapies for Warm Autoimmune Hemolytic Anemia, including Obexelimab (ZB012), Nipocalimab (M281), and others, are ...

During the last three months, 12 analysts shared their evaluations of Apellis Pharmaceuticals (NASDAQ: APLS), revealing diverse outlooks from bullish to bearish. The table below summarizes their ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $308.25, along with a high estimate of $342.00 and a low estimate of $261.00. Surpassing ...